Dr Mahipal S Sachdev, Chairman & Medical Director, Centre for Sight Group of Hospitals Cataract is the most common cause of decreased vision, especially among the geriatric population. About half the population by the age of 60 has cataract while around 80% of the people
The financial assistance will help StratMed leverage its Data-driven Supply Chain Optimization Platform to help hospitals in Tier 2 and 3 cities save operational and material costs without compromising on the quality of clinical outcomes. The SAMRIDH Healthcare Blended Financing Facility has committed INR 2.95
~to create awareness on occupational health situations in Agriculture ~ Over 1200 doctors trained in AIIMS hospitals and PHCs across Hyderabad, Nagpur and Rajkot Poisoning is a significant global public health hazard. The incidence of poisoning in India is among the highest in the world. It is
Medical Services and Infrastructure Development Corporation (APMSIDC) to facilitate the supply of Erba range of fully/semi-automated biochemistry analyzers, coagulation analyzers and urine chemistry analyzers. These are being installed in several Primary Health Centres, Urban Primary Health Centres, Community Health and Wellness Centres, Sub-District Hospitals and District
Medical Wing of Vidyamandir Classes, organizes Free Health Camp for its students In line with its philosophy of Student First, Vidyamandir Classes had organized a free Health Camp in association with The Birla Group of Hospitals & Centre For Sight, for all of its students' parents and
~The New Lab in Sambalpur is SRL’s 2nd lab in Odisha~ SRL Diagnostics, India’s largest diagnostics service provider today announced the launch of a new laboratory in Sambalpur, Odisha. The state of the art laboratory has the capacity to conduct 20,000+ tests in a month ranging
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y) EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q) EBITDA for
Price Band fixed at ₹ 319 to ₹ 336 per equity share of face value of ₹ 2 each of Global Health Limited (“Equity Shares”) Bid /Offer Opening Date – Thursday, November 03, 2022 and Bid/ Offer Closing Date – Monday, November 07, 2022 Global
Teleradiology Solutions (TRS), a leading global provider of remote radiology services, inaugurated its new centre at Andhra Med Tech Zone (AMTZ). Through this hub, AMTZ and TRS will reach out to pan-India government hospitals, state-wide rural health centres (including those under the National Health Mission),
To provide patients access to world-class treatment facilities and with a commitment to offering high-quality clinical care, HCG Cancer Hospital, Bengaluru, one of India’s largest dedicated cancer care Hospitals announced the launch of India’s first Varian Ethos™ therapy, an Artificial Intelligence (AI)-driven holistic solution designed
